Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51.1M
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
42.1M
-
Shares change
-
-1.43M
-
Total reported value, excl. options
-
$325M
-
Value change
-
-$15.5M
-
Put/Call ratio
-
0.55
-
Number of buys
-
88
-
Number of sells
-
-93
-
Price
-
$7.73
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q4 2024
226 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.1M shares
of 51.1M outstanding shares and own 82.28% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (5.47M shares), Redmile Group, LLC (4.79M shares), JPMORGAN CHASE & CO (4.14M shares), VANGUARD GROUP INC (2.99M shares), STATE STREET CORP (2.19M shares), MORGAN STANLEY (2M shares), MILLENNIUM MANAGEMENT LLC (1.32M shares), Balyasny Asset Management L.P. (1.19M shares), DIMENSIONAL FUND ADVISORS LP (1.17M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.09M shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.